AP
Asabys Partners
Venture CapitalModerateAsabys Partners is based in Barcelona and specialises in early-stage biotech, medical technology and healthcare innovation projects.
8
Investments
2
Exits
$300M
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Asabys Partners.
Investment Thesis & Strategy
Asabys Partners, a Barcelona-based VC, invests in early-stage biotech, medical technology, and healthcare innovation companies. They focus on identifying and supporting promising ventures within the life sciences sector.
Investment Activity
Deals per year over the last 7 years
1
20172
20180
20192
20201
20212
20222
2023Portfolio Companies
Selected investments from their portfolio of 8 companies
S
Splice Bio
Biotech · Series A, 2023
I
IDentifAI
Healthcare · Seed, 2023
I
Integra Therapeutics
Biotech · Series A, 2022
G
Gate2Brain
Biotech · Seed, 2022
D
DeepUll
Healthcare · Series A, 2021
O
Ona Therapeutics
Biotech · Series A, 2020
I
InBrain Neuroelectronics
Biotech · Series A, 2020
N
Nanoligent
Biotech · Series A, 2018
M
Mind the Byte
Biotech · Series A, 2018
G
GoodGut
Biotech · Series A, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
Oryzon GenomicsIPO2023—
Minoryx TherapeuticsAcquisition2022—
Frequently Asked Questions
Asabys Partners focuses on Series A, Series B, Series C+ stage investments.